Institutional investors purchased a net $4.7 thousand shares of BIOC during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 4.97% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 88.8 Thousand shares of Biocept Inc
UBS SECURITIES LLC Sold 437.00 shares of Biocept Inc
GROUP ONE TRADING LP Sold 600.00 shares of Biocept Inc